 |
Geerard Beets How to Approach the MMR Deficient Patient with Locally Advanced Colon Cancer |
 |
Geerard Beets Where Do We Stand with Lateral Compartment Lymphadenectomies |
 |
Geerard Beets Where Does the Evidence Stand in Support & Against Non-operative Management Strategies |
 |
Marylise Boutros Technical Considerations in the Treatment of Transverse Colon Cancers |
 |
Carl Brown How to Manage the T2 Tumour Overtreatment Oncologically or Undertreatment Functionally |
 |
Sean Cleary Oncologic & Technical Considerations with Stage IV Liver Disease |
 |
Julio Garcia-Aguilar D3 Lymphadenectomy in Colon Cancer Where Does the Evidence Stand |
 |
Faek Jamali Novel Therapies for Peritoneal Carcinomatosis HIPEC, PIPEC & Beyond |
 |
Uqba Khan CtDNA & Systemic Options in the Adjuvant Treatment of Stage II & Stage III Colon Cancer To Escalate or De-Escalate, That is The Question |
 |
Uqba Khan Immunotherapeutic Considerations Treating the MMR Deficient & Proficient Locally Advanced Rectal Cancer |
 |
Tsuyoshi Konishi Standardizing Your Approach to a Lateral Node Dissection and Where Can Things Go Wrong |
 |
Tsuyoshi Konishi Lateral Lymphadenectomy in Rectal Cancer What is the best parameter for its indication |
 |
Tsuyoshi Konishi Minimally Invasive Strategies in the Treatment of Recurrent Rectal Cancer |
 |
Tsuyoshi Konishi My Approach to a Laparoscopic D3 Lymphadenectomy for Right Sided Colon Cancer |
 |
Gonzalo Sapisochin Unresectable Metastatic Disease Considerations & Outcomes in Transplant Oncology |